This course is FREE with Unlimited CE!

Choose from two Unlimited CE subscription options and get access to 1000+ CE and professional development courses.

Get access starting at $49.95/yrLoading..

Goals and Learning Outcomes

Many state medical licensing boards have already or will soon require healthcare professionals to complete mandated continuing education that addresses prescribing controlled substances.  Misuse and abuse of prescribed controlled substances can lead to serious consequences, including addiction and overdose. Understanding the signs of abuse of medications such as opioids, sedatives, and stimulants is important to safe prescribing of controlled substances. This course will teach healthcare providers about substance use disorder and how to identify signs and symptoms of misuse and abuse. The course will also discuss a safe and effective approach to managing patients with substance use disorder.

The goal of this course is to educate healthcare providers on substance use disorder and how to identify patients who are misusing or abusing controlled substances.


After taking this course, you should be able to:

  • Educate healthcare providers on definition, prevalence, and risk factors for substance use disorder
  • Describe findings of patients who misuse or abuse common controlled substances such as opioids, sedatives, and stimulants
  • Discuss ways in which healthcare professionals can collaborate to intervene and assist patients with substance use disorder
  • Indicate the definition, prevalence, risk factors, and consequences of substance use disorder.
  • Recognize common symptoms and findings of patients who misuse or abuse common controlled substances such as opioids, sedatives, and stimulants.
  • Name ways in which healthcare professionals can collaborate to intervene, assist, or treat patients abusing prescription opioids, sedatives, or stimulants.

Course Termination Date: Not yet determined

Content Expiration Date: 12/31/24

Course Originally Released On: 02/01/22

Course Authors

4.4 Average

Course Reviews

26003 reviews

Accreditation Information

Nurse.com Accreditation

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, Kansas State Board of Nursing, Kentucky Board of Nursing, Michigan Board of Nursing, Mississippi Board of Nursing, New Hampshire Board of Nursing, New Mexico Board Of Nursing, North Dakota Board of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Registered Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.